A Practical Guide for Cardiologists to the Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease
Patients with type 2 diabetes are at increased cardiovascular risk. Until recently, reductions in HbA1c and the use of specific glucose-lowering agents have not had a clear, reproducible benefit in reducing the incidence of cardiovascular disease. However, over the past 5 years, members of two categ...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Radcliffe Medical Media
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/5a91fa8d33ae45ea8b5afd48cb104e34 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|